Piper Sandler raised the firm’s price target on Guardant Health (GH) to $60 from $50 and keeps an Overweight rating on the shares. The firm updated the company’s model post the earnings report.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health price target raised to $57 from $52 at Scotiabank
- Cathie Wood Loses Confidence in Palantir Stock (PLTR) Ahead of Q1 Earnings
- Guardant Health Reports Strong Q1 Revenue Growth
- Cathie Wood’s ARK Investment buys 186.8K shares of Guardant Health today
- Guardant Health price target raised to $60 from $56 at TD Cowen
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue